(redirected from Transmyocardial revascularization)
Also found in: Medical, Acronyms, Wikipedia.
Related to Transmyocardial revascularization: Arterial revascularization


v. re·vas·cu·lar·ized, re·vas·cu·lar·iz·ing, re·vas·cu·lar·iz·es
To reestablish the blood supply to (an organ or bodily part), especially by surgical procedure.
1. To revascularize an organ or bodily part.
2. To grow new blood vessels so as to establish blood supply: a graft that revascularizes slowly and takes a long time to heal.

re·vas′cu·la·ri·za′tion (-rĭ-zā′shən) n.


Restoring the blood supply to a part of the body.


n. revascularización, proceso de restauración de la sangre a una parte del cuerpo después de una lesión o una derivación quirúrgica.


n revascularización f
Mentioned in ?
References in periodicals archive ?
Country: , USASector: HealthcareTarget: PLC's transmyocardial revascularization businessBuyer: Novadaq Technologies IncVendor: PLC Systems IncDeal size in USD: 1mType: DivestmentStatus: Closed
Factors correlating with risk of mortality after transmyocardial revascularization.
The committee reviewed the data on transmyocardial revascularization and formulated recommendations that will be published in the society's journal, Innovations.
Compared with maximal medical therapy, transmyocardial revascularization reduced angina by at least two New York Heart Association classes and left more patients free of class III or IV angina at 1-5 years.
The company's market leading Holmium: YAG laser system and disposable fiber-optic accessories are used to perform a FDA-cleared surgical procedure known as Transmyocardial Revascularization (TMR) to treat patients suffering from angina.
CardioGenesis Corporation (Sunnyvale, CA; 408-328-8500), a leader in transmyocardial revascularization technology, yesterday filed an amended complaint asking the Federal District Court to consider evidence of inequitable conduct in the United States Patent and Trademark Office, while United States Patent 5,125,926 (the '926 patent) was being obtained by PLC Medical Systems, Inc.
CryoLife specialises in the treatment of coronary artery disease for severe angina using a laser console system and single-use, fiber-optic handpieces to perform a surgical procedure known as Transmyocardial Revascularization.
In 1999, NMMC became one of only two hospitals statewide to offer transmyocardial revascularization, a procedure that involves in filling tiny holes into the heart with a laser to relieve angina pain.
marketer and distributor of PLC's CO2 Heart Laser 2 system, which a cardiac surgeon can utilize to perform CO2 transmyocardial revascularization (TMR).
Patients with refractory angina who are not candidates for percutaneous or surgical revascularization may benefit from the emerging technologies of laser transmyocardial revascularization, enhanced electronic counterpulsation, or spinal cord stimulation, although there are limited long-term data regarding these devices/technologies.